Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots

NCT03537521 · clinicaltrials.gov ↗
WITHDRAWN
Status
OTHER
Sponsor class

Stopped due to corona pandemic crisis

Conditions

Interventions

Sponsor

Cardioangiologisches Centrum Bethanien